3
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Biological & Immunologicals: Interleukin-1β-converting enzyme-like apoptosis protease 3 and 4

Pages 1093-1096 | Published online: 29 Feb 2008

References

  • RAFE MC: Social controls on cell survival and cell death. Nature (1992) 356:397.
  • COHEN JJ: Apoptosis. Immunol. Today (1993) 14:126.
  • BARR PJ, TOMEI LD: Apoptosis and its role in human disease. Biotechnology (1994) 12:487.
  • EVAN GI, BROWN L, WHITE M, HARRINGTON E: Apop-tosis and the cell cycle. Curr. Biol. (1995) 7:825.
  • SMALE G, NICHOLS NR, BRADY DR, FINCH CE, HORTON WE: Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. (1995) 133:225.
  • ELLIS RE, YUAN J, HORVITZ FIR: Mechanisms and func-tions of cell death. Annu. Rev. Cell Biol. (1991) 7:663.
  • MARTIN SJ, GREEN DR: Protease activation during apop-tosis: death by a thousand cuts? Cell (1995) 82:349.
  • CHINNAIYAN AM, DIX1T VM: The cell-death machine. Curr. Biol. (1996) 6:555.
  • ELLIS HM, HORVITZ HR: Genetic control of programmed cell death in the nematode Caenorbabditis elegans. Cell (1986) 44:817.
  • YUAN JY, SHAHAM S, LEDOUX S, ELLIS HM, HORVITZ HR; The C elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-113-converting en-zyme. Cell (1993) 75:641.
  • MIURA M, ZHU H, ROTELLO R, HARTWEIG EA, YUAN J: Induction of apoptosis in fibroblasts by IL-ill-convert-ing enzyme, a mammalian homologue of the C. elegans cell death gene ced-3. Cell (1993) 75:633.
  • TEWARI M, QUAN LT, O'ROUKE K et al: Yama/CPP320 a mammalian homologue of CED-3 is a erm A-inhibitabk protease that cleaves the death substrate poly (ADP ribose) Polymerase. Cell (1995) 81:801.
  • KUMAR S, KINOSHITA M, NODA M, COPELAND NG, JENKINS NA: Induction of apoptosis by the mouseNedd2 gene, which encodes a protein similar to the product of the C elegans cell death gene ced-3 and the mammal-ian IL-113 converting enzyme. Genes Dev. (1994) 8:1613.
  • WANG L, MIURA M, BERGERON L, ZHU H, YUAN J: lch-1,an ICE-ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell (1994) 78:739.
  • KUIDA K, LIPPKE JA, KU G et al.: Altered cytokine export and apoptosis in mice deficient in interleukin- 1 con-verting enzyme. Science (1995) 267:2000.
  • NICHOLSON DW, ALI A, THOMBERRY NA et al.: Identifi-cation and inhibition of the ICE-CED-3 protease neces-sary for mammalian apoptosis. Nature (1995) 376:37.
  • PEITSCH MC, MANNHERZ HG, TSCHOPP J: The apoptosis endonuckases: cleaning up after cell death? Trends Cell. Biol. (1994) 4:37
  • KAYALAR C, ORD T, TESTA MP, ZHONG L, BREDESEN DE: Cleavage of actin by interleuk1n-l0-convert1ng enzyme to reverse DNase-1 inhibition. Proc. Natl. Acad. Sci. USA (1996) 93: 2234 .
  • LAZEBNIK YA, TAKAHASHI A, MOIR R et al.: Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA (1996) 92:9042
  • CASCIOLA-ROSEN LA, MILER DK, ANHALT GJ, ROSEN A: Specific cleavage of the 70 kDa protein component of small nuclear ribonucleoprotein is a characteristic bio-chemical feature of apoptotic cell death. J. Biol. Chem. (1994) 269:30757.
  • HENGARTNER MO, ELLIS RE, HORVITZ HR: Caenorbab-dtis elegans gene ced-9 protects from programmed cell death. Nature (1992) 356:494.
  • REED JC: Bc1-2 and the regulation of programmed cell death. J. Cell. Biol. (1994) 124:1.
  • COHEN JJ, AI-RUBEAI M: Apoptosis-targeted therapies: the 'next big thing' in biotechnology? Trends Biotech. (1995) 13:281.
  • NICHOLSON DW: ICE/CED-3-like proteases as therapeu-tic targets for the control of inappropriate apoptosis. Nat. Biotech. (1995) 14:297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.